KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Eli Lilly (LLY) Revenue (2016 - 2025)

Eli Lilly's Revenue history spans 17 years, with the latest figure at $19.3 billion for Q4 2025.

  • For Q4 2025, Revenue rose 42.55% year-over-year to $19.3 billion; the TTM value through Dec 2025 reached $65.2 billion, up 44.7%, while the annual FY2025 figure was $65.2 billion, 44.7% up from the prior year.
  • Revenue reached $19.3 billion in Q4 2025 per LLY's latest filing, up from $17.6 billion in the prior quarter.
  • In the past five years, Revenue ranged from a high of $19.3 billion in Q4 2025 to a low of $6.5 billion in Q2 2022.
  • Average Revenue over 5 years is $10.1 billion, with a median of $8.5 billion recorded in 2023.
  • Peak YoY movement for Revenue: fell 10.88% in 2023, then soared 53.87% in 2025.
  • A 5-year view of Revenue shows it stood at $8.0 billion in 2021, then dropped by 8.73% to $7.3 billion in 2022, then rose by 28.1% to $9.4 billion in 2023, then surged by 44.69% to $13.5 billion in 2024, then soared by 42.55% to $19.3 billion in 2025.
  • Per Business Quant, the three most recent readings for LLY's Revenue are $19.3 billion (Q4 2025), $17.6 billion (Q3 2025), and $15.6 billion (Q2 2025).